NEWS

Industry News

McKesson begins distributing Johnson & Johnson’s COVID-19 vaccine

On March 1, McKesson began distributing the COVID19 vaccine received from Janssen Pharmaceuticals, Inc., a part of Johnson & Johnson.

The Janssen vaccine received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on Feb. 27 and is the first one-shot COVID19 vaccine to be authorized for use in the U.S. McKesson was selected by the U.S. government in August 2020 to operate as the centralized distributor for frozen and refrigerated COVID-19 vaccines and ancillary supply kits needed to administer them.

In December 2020, McKesson began distributing the ancillary supply kits for Pfizer BioNTech’s COVID-19 vaccine. Later that month, the company began distributing Moderna’s COVID-19 vaccine and ancillary supply kits. McKesson has established four dedicated distribution centers which will be specifically used to distribute the Johnson & Johnson COVID-19 vaccine and future refrigerated vaccines. The U.S. government makes all program administration decisions, including where, when and how many vaccine doses McKesson will distribute.

B. Braun Medical names new CFO

B. Braun Medical Inc. announced that James Allen has joined the company’s Executive Leadership Team and will assume the role of SVP and CFO following a transition period. In this position, Allen will lead all financial operations of the

James Allen B. Braun group of companies in North America. Allen will replace Bruce Heugel, who last summer announced his decision to retire from B. Braun after more than twenty years of service. Heugel will transition responsibilities to Allen over the next several months, until he retires in May 2021.

Allen brings more than 30 years of finance and management experience across a range of industries and financial disciplines. He comes to B. Braun after serving for 6 years as an operating company CFO with Steel Partners, where he led the implementation of multiple successful growth initiatives. His previous experience includes 15 years at Johnson & Johnson in a variety of business development and financial leadership roles. He began his career at Amoco Corporation.

Cardinal Health collaborates with HIMSS Analytics as Certified Organization of new CISOM maturity model

Cardinal Health WaveMark Supply Management & Workflow Solutions has announced a collaboration with HIMSS Analytics as a Certified Organization of the Clinically Integrated Supply Outcomes Model (CISOM).nThe CISOM is an eight stage (0-7) model that provides a strategic pathway to track processes and products used in care by mobilizing data to create real-world evidence of impact and outcomes for patient populations.

The company says that the value WaveMark brings to CISOM is ensuring accurate visibility to “at risk” product inventory to help prevent “never events,” including expired or recalled product used on a patient. “A clinically integrated supply chain starts with WaveMark,” said Christina Tosto, VP of Operations at WaveMark. “We can help the clinical and supply chain teams in a health system to enhance the patient experience, ensure accurate clinical documentation of products used in patient care, and improve enterprise visibility to critical inventory and waste. The result is simply better care delivered more efficiently and at a lower cost.”